ConductScience.org, home

Paper37596643

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.

Glaviano A and 26 others. Mol Cancer, 2023. Cited by 1,779 papers, by iCite.

Cite this record

ConductScience Library. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Papers, record 37596643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37596643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
PubMed
Journal
Mol Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,779
iCite
Relative citation ratio, by iCite
207
iCite
Revised in PubMed
2024-10-12
PubMed

Authors27

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Glaviano AAntonino
2Foo ASCAaron S C
3Lam HYHiu Y
4Yap KCHKenneth C H
5Jacot WWilliam
6Jones RHRobert H
7Eng HHuiyan
8Nair MGMadhumathy G
9Makvandi PPooyan
10Geoerger BBirgit
11Kulke MHMatthew H
12Baird RDRichard D
13Prabhu JSJyothi S
14Carbone DDaniela
15Pecoraro CCamilla
16Teh DBLDaniel B L
17Sethi GGautam
18Cavalieri VVincenzo
19Lin KHKevin H
20Javidi-Sharifi NRNathalie R

Source PubMed

See all 27 authorsDownload CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Phosphatidylinositol 3-KinasesMajor topic
NeoplasmsMajor topic
Humans
Proto-Oncogene Proteins c-akt
Signal Transduction
TOR Serine-Threonine Kinases

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07811297A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM CancersBackground

Source ClinicalTrials.gov

Download CSV of trials

References426

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115930273Functional analysis of PIK3CA gene mutations in human colorectal cancer.Cancer Res2005https://conductscience.org/library/papers/15930273PubMed
227826244Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives.Front Pharmacol2016https://conductscience.org/library/papers/27826244PubMed
335250965mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.Front Immunol2021https://conductscience.org/library/papers/35250965PubMed
422722201The landscape of cancer genes and mutational processes in breast cancer.Nature2012https://conductscience.org/library/papers/22722201PubMed
532451180Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.Eur Urol2020https://conductscience.org/library/papers/32451180PubMed
634320785Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.Haematologica2022https://conductscience.org/library/papers/34320785PubMed
725488966Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.J Clin Oncol2015https://conductscience.org/library/papers/25488966PubMed
816341149The Akt pathway in human breast cancer: a tissue-array-based analysis.Mod Pathol2006https://conductscience.org/library/papers/16341149PubMed
935484662Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.Haematologica2022https://conductscience.org/library/papers/35484662PubMed
1035118422The present and future of PI3K inhibitors for cancer therapy.Nat Cancer2021https://conductscience.org/library/papers/35118422PubMed
1127097161Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway.PLoS One2016https://conductscience.org/library/papers/27097161PubMed
1226403194Regulation of innate immune cell function by mTOR.Nat Rev Immunol2015https://conductscience.org/library/papers/26403194PubMed
1319644473Targeting the phosphoinositide 3-kinase pathway in cancer.Nat Rev Drug Discov2009https://conductscience.org/library/papers/19644473PubMed
1436646410The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.Cancer Lett2023https://conductscience.org/library/papers/36646410PubMed
1514598361Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth.J Surg Oncol2003https://conductscience.org/library/papers/14598361PubMed
1637311901Capivasertib delays disease progression.Nat Rev Clin Oncol2023https://conductscience.org/library/papers/37311901PubMed
1726703889Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.Lancet2016https://conductscience.org/library/papers/26703889PubMed
1833175607Long non-coding RNA IGF2-AS represses breast cancer tumorigenesis by epigenetically regulating IGF2.Exp Biol Med (Maywood)2021https://conductscience.org/library/papers/33175607PubMed
1921878902Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination.Mol Ther2011https://conductscience.org/library/papers/21878902PubMed
2033352201Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial.Ann Oncol2021https://conductscience.org/library/papers/33352201PubMed

See all 426 referencesDownload CSV of references

Cited by1,345

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,779 citations.

PMIDTitleJournalYearIn PapersSource
42978971Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities.Front Cell Dev Biol2026https://conductscience.org/library/papers/42978971PubMed
42976151Exogenous tryptophan aggravates experimental lung fibrosis through activation of AKT-mTORC1 pathway.PLoS One2026https://conductscience.org/library/papers/42976151PubMed
42967165Unraveling the EMT Spectrum in Aggressive Breast Cancer: Bridging Molecular Hybrid States with Functional Assay Interpretation.Onco Targets Ther2026https://conductscience.org/library/papers/42967165PubMed
42959329Macrophage lipophagy in atherosclerosis: from molecular mechanisms to traditional Chinese medicine interventions.Front Pharmacol2026https://conductscience.org/library/papers/42959329PubMed
42958602Glioblastoma as a dynamic tumor ecosystem: from molecular alterations to therapeutic translation.Exp Hematol Oncol2026https://conductscience.org/library/papers/42958602PubMed
42958312The effects of root decay on the anti-tumor potential of Scutellariae Radix: an investigation using mass spectrometry imaging, network pharmacology and in vitro validation.BMC Complement Med Ther2026https://conductscience.org/library/papers/42958312PubMed
42948500Exposure duration shapes GenX-induced transcriptomics responses in 3D HepG2/C3A spheroids.Front Toxicol2026https://conductscience.org/library/papers/42948500PubMed
42943327Mechanistic Profiling of Phenethyl Isothiocyanate in CCRF-CEM Acute Lymphoblastic Leukemia Cells.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943327PubMed
42943210Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943210PubMed
42942134USP30 Beyond Mitophagy: A Context-Dependent Deubiquitinase in Cancer Progression.Int J Mol Sci2026https://conductscience.org/library/papers/42942134PubMed
42942008PSY Inhibits Colorectal Cancer Growth and Exhibits an In Vitro Synergistic Interaction with 5-Fluorouracil.Int J Mol Sci2026https://conductscience.org/library/papers/42942008PubMed
42930470Recent Advances in Fucoidan Bioactivity and Its Molecular Mechanisms in the Intervention of Vascular Cognitive Impairment.Mar Drugs2026https://conductscience.org/library/papers/42930470PubMed
42927612SIRT7 Mediated-PTEN Desuccinylation Drives Gastric Tumorigenesis by Activating PI3K/AKT Pathway.J Biochem Mol Toxicol2026https://conductscience.org/library/papers/42927612PubMed
42926813PTHrP suppresses BMP2-induced osteochondral differentiation and preserves cartilage phenotype in mesenchymal stem cells via inactivating PI3K-AKT signaling.Genes Dis2027https://conductscience.org/library/papers/42926813PubMed
42924596Mechanisms and therapeutic implications of ferritinophagy in fibrotic diseases (Review).Int J Mol Med2026https://conductscience.org/library/papers/42924596PubMed
42920362Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models.FEBS Open Bio2026https://conductscience.org/library/papers/42920362PubMed
42909819Gedatolisib: First Approval.Drugs2026https://conductscience.org/library/papers/42909819PubMed
42908866MKRN2 promotes gastric cancer progression by suppressing autophagy via the PI3K/Akt/mTOR signaling pathway.Am J Cancer Res2026https://conductscience.org/library/papers/42908866PubMed
42890088Signaling Pathways Mediating the Cytotoxicity of (E)-4-(1-Epoxy-7,8-propenyl)phenyl Benzoate, a Phenylpropanoid from Croton velutinus, in MCF‑7 Cells.ACS Omega2026https://conductscience.org/library/papers/42890088PubMed
42889412Epigenetic regulation of immune checkpoint signaling by microbial metabolites: mechanisms, therapeutic potential, and future perspectives.Front Immunol2026https://conductscience.org/library/papers/42889412PubMed

See all 1,345 cited byDownload CSV of cited by

Genes150

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AKT1S184335PubTator's text mininghttps://conductscience.org/library/genes/84335NCBI Gene
AKT2208PubTator's text mininghttps://conductscience.org/library/genes/208NCBI Gene
AKT310000PubTator's text mininghttps://conductscience.org/library/genes/10000NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
ATF21386PubTator's text mininghttps://conductscience.org/library/genes/1386NCBI Gene
ATG4B23192PubTator's text mininghttps://conductscience.org/library/genes/23192NCBI Gene
ATP7A538PubTator's text mininghttps://conductscience.org/library/genes/538NCBI Gene
BAK1578PubTator's text mininghttps://conductscience.org/library/genes/578NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BBC327113PubTator's text mininghttps://conductscience.org/library/genes/27113NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
BIRC3330PubTator's text mininghttps://conductscience.org/library/genes/330NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CCNA2890PubTator's text mininghttps://conductscience.org/library/genes/890NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDC42998PubTator's text mininghttps://conductscience.org/library/genes/998NCBI Gene

See all 150 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37596643

GET https://conductscience.org/api/papers/v1/37596643/authors?page=2